PCN3I EVALUATION OF PEMETREXED VERSUS DOCETAXEL IN THE SECOND-LINE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER- PATIENT PREFERENCE AND WILLINGNESS-TO-PAYWITH DISCRETE CHOICE CONJOINT ANALYSIS
Abstract
Authors
AJ Brown M Aristides PE Fitzgerald AM Liepa MJ Boyer SA Clarke